6. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Lacourcière, Yves
Bélanger, André
Godin, Chantal
Hallé, Jean-Pierre
Ross, Stuart
Wright, Noël
Marion, Jean

August 2000

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics w...

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Mogensen, C. E.
Neldam, S.
Tikkanen, I.
Oren, S.
Viskoper, R.
Watts, Richard Walter
Cooper, Mark E.

January 2000

Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With

September 2016

Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with type 2 diabe...

Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, Barry M., 1937-
Cooper, Mark E.
De Zeeuw, Dick
Keane, William F.
Mitch, William E.
Parving, Hans-Henrik
Remuzzi, Giuseppe
Snapinn, Steven M.
Zhang, Zhonxin
Shahinfar, Shahnaz
Martínez Castelao, Alberto
RENAAL Study Investigators

Background: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of th...

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, BM
Cooper, ME
de Zeeuw, D
Keane, WF
Mitch, WE
Parving, HH
Remuzzi, G
Snapinn, SM
Zhang, ZX
Shahinfar, S

September 2001

Background Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the...

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus - A randomized clinical trial

Zandbergen, AAM
Baggen, MGA
Bootsma, AH
de Zeeuw, D
Ouwendijk, RJT
LAMBERTS, SWJ

July 2003

Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in normotens...

Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy

Philips, Jean-Christophe
Weekers, Laurent
Scheen, André

January 2001

peer reviewedThe main objective of the CALM (Candesartan And Lisinopril Microalbuminuria) study is t...

Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes Mellitus

A Randomized
Clinical Trial

October 2016

shown antiproteinuric effects in normotensive and hypertensive diabetic patients. Angiotensin-recept...

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial

Zandbergen, Adrienne
Baggen, Marinus
Lamberts, Steven
Bootsma, Aart
Zeeuw, Dick
Ouwendijk, Rob

January 2003

textabstractBACKGROUND: Angiotensin-converting enzyme inhibitors have shown antiproteinuric ef...

EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Mogensen Ce
Neldam S
Tikkanen I Et Al
Teo Kk
Pogue J
Dyal L Et Al. Telmisartan
Bakris Gl
Ruilope L
Locatelli F Et Al
Julia Platts

October 2015

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertensi...

Losartan and diabetic nephropathy: commentaries on the RENAAL study

Tenenbaum Alexander
Fisman Enrique Z
Motro Michael

April 2002

Abstract The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) st...

Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive Type 1 diabetic subjects

Acbay, O

January 2001

To examine the effect of low-dose losartan, an angiotensin II antagonist, on persistent microalbumin...

Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes

Burnier, M.
Zanchi, A.

January 2006

Diabetes (particularly type 2 diabetes) represents a global health problem of epidemic proportions. ...

Losartan in patients with renal insufficiency

De Zeeuw, D.
Gansevoort, R. T.
De Jong, P. E.

August 1995

A choice of many antihypertensive strategies is not offered for the treatment of the hypertensive pa...

Inhibition of the renin-angiotensin system in normotensive type 2 diabetes: effects and mechanisms of action

Zandbergen, Adrienne

April 2007

textabstractThe majority of clinical trials, investigating the effects of angiotensin-receptor antag...

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Lacourcière, Yves
Bélanger, André
Godin, Chantal
Hallé, Jean-Pierre
Ross, Stuart
Wright, Noël
Marion, Jean

August 2000

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics w...

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Mogensen, C. E.
Neldam, S.
Tikkanen, I.
Oren, S.
Viskoper, R.
Watts, Richard Walter
Cooper, Mark E.

January 2000

Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With

September 2016

Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with type 2 diabe...

Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, Barry M., 1937-
Cooper, Mark E.
De Zeeuw, Dick
Keane, William F.
Mitch, William E.
Parving, Hans-Henrik
Remuzzi, Giuseppe
Snapinn, Steven M.
Zhang, Zhonxin
Shahinfar, Shahnaz
Martínez Castelao, Alberto
RENAAL Study Investigators

Background: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of th...

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, BM
Cooper, ME
de Zeeuw, D
Keane, WF
Mitch, WE
Parving, HH
Remuzzi, G
Snapinn, SM
Zhang, ZX
Shahinfar, S

September 2001

Background Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the...

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus - A randomized clinical trial

Zandbergen, AAM
Baggen, MGA
Bootsma, AH
de Zeeuw, D
Ouwendijk, RJT
LAMBERTS, SWJ

July 2003

Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in normotens...

Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy

Philips, Jean-Christophe
Weekers, Laurent
Scheen, André

January 2001

peer reviewedThe main objective of the CALM (Candesartan And Lisinopril Microalbuminuria) study is t...

Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes Mellitus

A Randomized
Clinical Trial

October 2016

shown antiproteinuric effects in normotensive and hypertensive diabetic patients. Angiotensin-recept...

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial

Zandbergen, Adrienne
Baggen, Marinus
Lamberts, Steven
Bootsma, Aart
Zeeuw, Dick
Ouwendijk, Rob

January 2003

textabstractBACKGROUND: Angiotensin-converting enzyme inhibitors have shown antiproteinuric ef...

EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Mogensen Ce
Neldam S
Tikkanen I Et Al
Teo Kk
Pogue J
Dyal L Et Al. Telmisartan
Bakris Gl
Ruilope L
Locatelli F Et Al
Julia Platts

October 2015

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertensi...

Losartan and diabetic nephropathy: commentaries on the RENAAL study

Tenenbaum Alexander
Fisman Enrique Z
Motro Michael

April 2002

Abstract The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) st...

Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive Type 1 diabetic subjects

Acbay, O

January 2001

To examine the effect of low-dose losartan, an angiotensin II antagonist, on persistent microalbumin...

Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes

Burnier, M.
Zanchi, A.

January 2006

Diabetes (particularly type 2 diabetes) represents a global health problem of epidemic proportions. ...

Losartan in patients with renal insufficiency

De Zeeuw, D.
Gansevoort, R. T.
De Jong, P. E.

August 1995

A choice of many antihypertensive strategies is not offered for the treatment of the hypertensive pa...

Inhibition of the renin-angiotensin system in normotensive type 2 diabetes: effects and mechanisms of action

Zandbergen, Adrienne

April 2007

textabstractThe majority of clinical trials, investigating the effects of angiotensin-receptor antag...

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

Lacourcière, Yves
Bélanger, André
Godin, Chantal
Hallé, Jean-Pierre
Ross, Stuart
Wright, Noël
Marion, Jean

August 2000

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics w...

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

Mogensen, C. E.
Neldam, S.
Tikkanen, I.
Oren, S.
Viskoper, R.
Watts, Richard Walter
Cooper, Mark E.

January 2000

Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With

September 2016

Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with type 2 diabe...

6. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and

Abstract

Extracted data

6. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and

Abstract

Extracted data

Related items

Related items